SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial

被引：0

作者：

Landau, D. B. ^{[1
]}

Hughes, L. ^{[2
,3
]}

Ngai, Y. ^{[2
,3
]}

Hanna, G. G. ^{[4
]}

Conibear, J. ^{[5
]}

Farrelly, L. ^{[2
,3
]}

Counsell, N. ^{[2
,3
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, Oncol, EH, London, England

[2] CRUK, London, England

[3] UCL Canc Trials Ctr, Inst Canc, TJ, London, England

[4] Queens Univ Belfast, Ctr Canc Res & Cell Biol, AE, Belfast, Antrim, North Ireland

[5] St Bartholomews Hosp, Barts Canc Inst, BE, London, England

来源：

LUNG CANCER | 2017年 / 103卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

119

引用

页码：S54 / S54

页数：1

共 50 条

[1] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
McDonald, F.
Mak, K. M.
Teague, J.
Landau, D.
Hanna, G.
Farrelly, L.
Counsell, N.
LUNG CANCER, 2020, 139 : S91 - S91
[2] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial
Ngai, Yenting
Hanna, Gerard
Conibear, John
Counsell, Nicholas
Hughes, Laura
Farrelly, Laura
Landau, David
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1425 - S1426
[3] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
Mak, Ka-Man
McDonald, Fiona
Teague, Jonathan
Faivre-Finn, Corinne
Forster, Martin
Hanna, Gerard
Moinuddin, Syed
Conibear, John
Harden, Susan
Popat, Sanjay
Califano, Raffaele
Farrelly, Laura
Counsell, Nicholas
Saron, T. M. G.
LUNG CANCER, 2022, 165 : S71 - S71
[4] Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
Conibear, John
Chia, Brendan
Ngai, Yenting
Bates, Andrew Tom
Counsell, Nicholas
Patel, Rushil
Eaton, David
Faivre-Finn, Corinne
Fenwick, John
Forster, Martin
Hanna, Gerard G.
Harden, Susan
Mayles, Philip
Moinuddin, Syed
Landau, David
BMJ OPEN, 2018, 8 (04):
[5] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
Verma, Vivek
Chang, Joe Y.
JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
[6] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
Dohopolski, Michael
Iyengar, Puneeth
ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
[7] Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)
Conibear, John
Chia, Brendan
Ngai, Yenting
Bates, Andrew Tom
Counsell, Nicholas
Patel, Rushil
Eaton, David
Faivre-Finn, Corinne
Fenwick, John
Forster, Martin
Hanna, Gerard G.
Harden, Susan
Mayles, Philip
Moinuddin, Syed
Landau, David
Franks, Kevin
Ahmed, Merina
Harrow, Stephen
Mendes, Ruheena
Hatfield, Paul
Tsang, Yat Man
Mak, Ka Man
Farrelly, Laura
Conibear, John
Chia, Brendan
Ngai, Yenting
Bates, Andrew Tom
Counsell, Nicholas
Patel, Rushil
Eaton, David
Faivre-Finn, Corinne
Fenwick, John
Forster, Martin
Hanna, Gerard G.
Harden, Susan
Mayles, Philip
Moinuddin, Syed
Landau, David
BMJ OPEN, 2019, 9 (05):
[8] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
Ricardi, Umberto
Levra, Niccolo Giaj
Badellino, Serena
Alongi, Filippo
JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
[9] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
Suh, Yang-Gun
Cho, Jaeho
RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
[10] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
Leschenko, Y.
Chebotareva, T.
Spizhenko, N.
Fedusenko, A.
Sharaevskiy, O.
Buryk, V.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39

← 1 2 3 4 5 →